Dent Neurologic



Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS

Inclusion Criteria

  • ALS/Lou Gehrig’s Disease
  • **other criteria will apply

For more information, call Anna Mattle at 716-961-9217 or email You can also visit:

Subscribe To Our Newsletter

Sign up to receive email updates on announcements, new services added, company updates & more!

Want to participate in a study?

Fill out the form below and one of our Research Coordinators will be in contact with you as soon as possible. If we currently do not have a study that is currently available for you, we will add you to our database for future studies.

Scroll to Top